Interventional Cardiology and Peripheral Vascular Devices Market By Type (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Accessories), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global interventional cardiology and peripheral vascular devices market size was valued at $17,960.8 million in 2020, and is projected to reach $41,900.3 million by 2030, registering a CAGR of 8.5% from 2021 to 2030. Interventional cardiology is a branch of cardiology that focuses on treatment by using catheter-based technologies.
Interventional cardiology and peripheral vascular devices typically consist of balloons, catheters, guidewires, stents, and filters. These devices are used for treating peripheral vascular disorders that affect the circulatory system, resulting in plaque built-up in the arteries of arms and legs.
The surge in number of patients suffering from various cardiovascular diseaseshas significantly increased owing to rise in geriatric population and changing lifestyle. This creates a demand for devices that can effectively treat various cardiovascular disorders, thereby, positively influencing the growth of the market. However, factors such as high treatment cost and stringent rules for approval of interventional cardiology and peripheral vascular devices can restraintthe market growth. Furthermore, rapid development of healthcare infrastructure in developing countries fueled by increased investment provides lucrative growth opportunities for the market.
The interventional cardiology and peripheral vascular devices market is segmented on the basis of product, end user, and region.By product, the market is classified into angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. By end user, it is segmented into hospitals, ambulatory surgical centers, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players operating in the global market have adopted key strategies such as product launch to strengthen their market outreach and sustain the stiff competition in the market
Competition Analysis
The major market participants profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cook Medical, Koninklijke Philips N.V., Medtronic plc. and Terumo Corporation.
Key Benefits for Stakeholders
The report provides an extensive analysis of the current and emerging interventional cardiology and peripheral vascular devices market trends and dynamics.
In-depth market analysis is conducted by constructing market estimations for the key market segments between 2020 and 2030.
Extensive analysis of the interventional cardiology and peripheral vascular devices market is conducted by following key product positioning and monitoring of the top competitors within the market framework.
A comprehensive analysis of all regions is provided to determine the prevailing opportunities.
The global interventional cardiology and peripheral vascular devices market forecast analysis from 2021 to 2030 is included in the report.
The key market players within interventional cardiology and peripheral vascular devices market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the interventional cardiology and peripheral vascular devices industry.
Key Market Segments
By Type
Inferior Vena Cava (IVC) Filters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Accessories
Angioplasty Balloons
Angioplasty Stents
Angioplasty Catheters
Endovascular Aneurysm Repair Stent Grafts
By End User
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
Rest Of Asia Pacific
LAMEA
Latin America
Middle East
Africa
Key Market Players
Abbott Laboratories
B. Braun Melsungen AG
Boston Scientific Corporation
Becton, Dickinson and Company.
Cardinal Health Inc.
Cook Group
Medtronic plc
Terumo Group
Koninklijke Philips N.V.
Biotronik SE & Co. KG
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Angioplasty Balloons
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Angioplasty Stents
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Angioplasty Catheters
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Endovascular Aneurysm Repair Stent Grafts
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Inferior Vena Cava (IVC) Filters
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
- 4.7 Plaque Modification Devices
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country
- 4.8 Hemodynamic Flow Alteration Devices
- 4.8.1 Key market trends, growth factors and opportunities
- 4.8.2 Market size and forecast, by region
- 4.8.3 Market analysis by country
- 4.9 Accessories
- 4.9.1 Key market trends, growth factors and opportunities
- 4.9.2 Market size and forecast, by region
- 4.9.3 Market analysis by country
- CHAPTER 5: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Hospitals
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Ambulatory Surgical Centers
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Type
- 6.2.3 North America Market size and forecast, by End User
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Market size and forecast, by Type
- 6.2.4.1.2 Market size and forecast, by End User
- 6.2.4.2 Canada
- 6.2.4.2.1 Market size and forecast, by Type
- 6.2.4.2.2 Market size and forecast, by End User
- 6.2.4.3 Mexico
- 6.2.4.3.1 Market size and forecast, by Type
- 6.2.4.3.2 Market size and forecast, by End User
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Type
- 6.3.3 Europe Market size and forecast, by End User
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Market size and forecast, by Type
- 6.3.4.1.2 Market size and forecast, by End User
- 6.3.4.2 France
- 6.3.4.2.1 Market size and forecast, by Type
- 6.3.4.2.2 Market size and forecast, by End User
- 6.3.4.3 U.K.
- 6.3.4.3.1 Market size and forecast, by Type
- 6.3.4.3.2 Market size and forecast, by End User
- 6.3.4.4 Spain
- 6.3.4.4.1 Market size and forecast, by Type
- 6.3.4.4.2 Market size and forecast, by End User
- 6.3.4.5 Rest of Europe
- 6.3.4.5.1 Market size and forecast, by Type
- 6.3.4.5.2 Market size and forecast, by End User
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Type
- 6.4.3 Asia-Pacific Market size and forecast, by End User
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 China
- 6.4.4.1.1 Market size and forecast, by Type
- 6.4.4.1.2 Market size and forecast, by End User
- 6.4.4.2 Japan
- 6.4.4.2.1 Market size and forecast, by Type
- 6.4.4.2.2 Market size and forecast, by End User
- 6.4.4.3 India
- 6.4.4.3.1 Market size and forecast, by Type
- 6.4.4.3.2 Market size and forecast, by End User
- 6.4.4.4 Australia
- 6.4.4.4.1 Market size and forecast, by Type
- 6.4.4.4.2 Market size and forecast, by End User
- 6.4.4.5 Rest Of Asia Pacific
- 6.4.4.5.1 Market size and forecast, by Type
- 6.4.4.5.2 Market size and forecast, by End User
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Type
- 6.5.3 LAMEA Market size and forecast, by End User
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Latin America
- 6.5.4.1.1 Market size and forecast, by Type
- 6.5.4.1.2 Market size and forecast, by End User
- 6.5.4.2 Middle East
- 6.5.4.2.1 Market size and forecast, by Type
- 6.5.4.2.2 Market size and forecast, by End User
- 6.5.4.3 Africa
- 6.5.4.3.1 Market size and forecast, by Type
- 6.5.4.3.2 Market size and forecast, by End User
- CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
- CHAPTER 8: COMPANY PROFILES
- 8.1 Abbott Laboratories
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 B. Braun Melsungen AG
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 Boston Scientific Corporation
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 Becton, Dickinson and Company.
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 Cardinal Health Inc.
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 Cook Group
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 Medtronic plc
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 Terumo Group
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 Koninklijke Philips N.V.
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- 8.10 Biotronik SE & Co. KG
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 2. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ANGIOPLASTY BALLOONS, BY REGION , 2020-2030,($MILLION)
- TABLE 3. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ANGIOPLASTY BALLOONS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 4. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ANGIOPLASTY STENTS, BY REGION , 2020-2030,($MILLION)
- TABLE 5. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ANGIOPLASTY STENTS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 6. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ANGIOPLASTY CATHETERS, BY REGION , 2020-2030,($MILLION)
- TABLE 7. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ANGIOPLASTY CATHETERS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 8. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, BY REGION , 2020-2030,($MILLION)
- TABLE 9. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 10. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR INFERIOR VENA CAVA (IVC) FILTERS, BY REGION , 2020-2030,($MILLION)
- TABLE 11. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET INFERIOR VENA CAVA (IVC) FILTERS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 12. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR PLAQUE MODIFICATION DEVICES, BY REGION , 2020-2030,($MILLION)
- TABLE 13. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET PLAQUE MODIFICATION DEVICES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 14. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION , 2020-2030,($MILLION)
- TABLE 15. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET HEMODYNAMIC FLOW ALTERATION DEVICES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 16. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ACCESSORIES, BY REGION , 2020-2030,($MILLION)
- TABLE 17. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ACCESSORIES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 18. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 19. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
- TABLE 20. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 21. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS, BY REGION , 2020-2030,($MILLION)
- TABLE 22. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET AMBULATORY SURGICAL CENTERS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 23. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
- TABLE 24. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 25. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2030,($MILLION)
- TABLE 26. NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 27. NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 28. NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 29. U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 30. U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 31. CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 32. CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 33. MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 34. MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 35. EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 36. EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 37. EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 38. GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 39. GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 40. FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 41. FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 42. U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 43. U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 44. SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 45. SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 46. REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 47. REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 48. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 49. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 50. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 51. CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 52. CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 53. JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 54. JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 55. INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 56. INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 57. AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 58. AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 59. REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 60. REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 61. LAMEA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 62. LAMEA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 63. LAMEA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 64. LATIN AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 65. LATIN AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 66. MIDDLE EAST INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 67. MIDDLE EAST INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 68. AFRICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 69. AFRICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 70.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 71.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 72.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 73.ABBOTT LABORATORIES: NET SALES,
- TABLE 74.ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 75.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
- TABLE 76.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
- TABLE 77.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
- TABLE 78.B. BRAUN MELSUNGEN AG: NET SALES,
- TABLE 79.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
- TABLE 80.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 81.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 82.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 83.BOSTON SCIENTIFIC CORPORATION: NET SALES,
- TABLE 84.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
- TABLE 85.BECTON, DICKINSON AND COMPANY.: COMPANY SNAPSHOT
- TABLE 86.BECTON, DICKINSON AND COMPANY.: OPERATING SEGMENTS
- TABLE 87.BECTON, DICKINSON AND COMPANY.: PRODUCT PORTFOLIO
- TABLE 88.BECTON, DICKINSON AND COMPANY.: NET SALES,
- TABLE 89.BECTON, DICKINSON AND COMPANY.: KEY STRATERGIES
- TABLE 90.CARDINAL HEALTH INC.: COMPANY SNAPSHOT
- TABLE 91.CARDINAL HEALTH INC.: OPERATING SEGMENTS
- TABLE 92.CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
- TABLE 93.CARDINAL HEALTH INC.: NET SALES,
- TABLE 94.CARDINAL HEALTH INC.: KEY STRATERGIES
- TABLE 95.COOK GROUP: COMPANY SNAPSHOT
- TABLE 96.COOK GROUP: OPERATING SEGMENTS
- TABLE 97.COOK GROUP: PRODUCT PORTFOLIO
- TABLE 98.COOK GROUP: NET SALES,
- TABLE 99.COOK GROUP: KEY STRATERGIES
- TABLE 100.MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 101.MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 102.MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 103.MEDTRONIC PLC: NET SALES,
- TABLE 104.MEDTRONIC PLC: KEY STRATERGIES
- TABLE 105.TERUMO GROUP: COMPANY SNAPSHOT
- TABLE 106.TERUMO GROUP: OPERATING SEGMENTS
- TABLE 107.TERUMO GROUP: PRODUCT PORTFOLIO
- TABLE 108.TERUMO GROUP: NET SALES,
- TABLE 109.TERUMO GROUP: KEY STRATERGIES
- TABLE 110.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- TABLE 111.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
- TABLE 112.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
- TABLE 113.KONINKLIJKE PHILIPS N.V.: NET SALES,
- TABLE 114.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
- TABLE 115.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
- TABLE 116.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
- TABLE 117.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
- TABLE 118.BIOTRONIK SE & CO. KG: NET SALES,
- TABLE 119.BIOTRONIK SE & CO. KG: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION
- FIGURE 2.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030
- FIGURE 3.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,BY TYPE,2020(%)
- FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ANGIOPLASTY BALLOONS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANGIOPLASTY STENTS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ANGIOPLASTY CATHETERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF INFERIOR VENA CAVA (IVC) FILTERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PLAQUE MODIFICATION DEVICES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HEMODYNAMIC FLOW ALTERATION DEVICES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ACCESSORIES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 20.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,BY END USER,2020(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOSPITALS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
- FIGURE 24.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY REGION,2020
- FIGURE 25.U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 26.CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 27.MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 28.GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 29.FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 30.U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 31.SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 32.REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 33.CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 34.JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 35.INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 36.AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 37.REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 38.LATIN AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 39.MIDDLE EAST INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 40.AFRICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
- FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 45.COMPETITIVE DASHBOARD
- FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 47.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
- FIGURE 48.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
- FIGURE 49.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
- FIGURE 50.BECTON, DICKINSON AND COMPANY..: NET SALES ,($MILLION)
- FIGURE 51.CARDINAL HEALTH INC..: NET SALES ,($MILLION)
- FIGURE 52.COOK GROUP.: NET SALES ,($MILLION)
- FIGURE 53.MEDTRONIC PLC.: NET SALES ,($MILLION)
- FIGURE 54.TERUMO GROUP.: NET SALES ,($MILLION)
- FIGURE 55.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
- FIGURE 56.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook